Клиническая онкогематология. Фундаментальные исследования и клиническая практика
Clinical Oncohematology. Basic Research and Clinical Practice
ISSN
1997-6933
(print)
ISSN
2500-2139
(online)
Register
Login
Skip to main content
Skip to main navigation menu
Skip to site footer
Open Menu
Clinical Oncohematology
Basic Research and Clinical Practice
ИФ РИНЦ:
0,587
H-INDEX:
16
Home
About the Journal
Aims and Scope
Editorial Board
Peer Review
Publishing Ethics and Malpractice Statement
Indexing and Abstracting
Ownership, management and funding
Open Access Policy and Publication Fee
Articles
Current
Journal pre-proofs
Archive
SUPPLEMENT
Sections
LYMPHOID TUMORS
MYELOID TUMORS
BONE MARROW TRANSPLANTATION
ANEMIAS
AUTOIMMUNE DISEASES
CLINICAL TRIALS
NOVEL CORONAVIRUS INFECTION
NEWS
NEW TECHNOLOGIES
REVIEWS
COMPLICATIONS OF CHEMOTHERAPY
PRACTICAL RECOMMENDATIONS
RARE HEMATOLOGICAL TUMORS AND SYNDROMES
EXPERIMENTAL STUDIES
Submission
Search
Register
Login
Home
/
NEWS
NEWS
Consensus Following the Meeting of Multiple Myeloma Expert Panel
238-240
01.04.2026
New Prospects and Treatment Decisions for Oncohematological Patients
(Resolution of Expert Panel)
410-413
01.10.2025
Perspectives for the Use of Bispecific Antibodies in the Third- and Subsequent-Line Therapies of Follicular Lymphoma (Resolution of Expert Panel)
227-228
03.03.2023
Treatment Opportunities in Relapsed Hodgkin’s Lymphoma and Non-Hodgkin’s Lymphomas (Resolution of Expert Panel)
513-514
01.10.2021
AstraZeneca company press-release
391-393
01.07.2021
Takeda company press-release
396-398
01.07.2021
Sanofi company press-release
394-395
01.07.2021
The Improvement of Treatment Outcomes in Multiple Myeloma Patients Non-Eligible for HDCT and Auto-HSCT Using New Approaches to Early Lines of Therapy (Meeting of Expert Panel)
430-432
01.10.2020
Breakthrough Hemolysis as a Challenging Issue in Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria (Resolution of Expert Panel)
354-356
01.07.2020
AstraZeneca Company Press-Release
231-234
01.04.2020
AbbVie Company Press-Release
235-237
01.04.2020
Obituary in memory of G.I. Kozineс
238
01.04.2020
Challenges in the Treatment of Primary Refractory and Relapsed Diffuse Large B-cell Lymphoma in the Russian Federation. What will the future hold?
112-114
01.01.2020
Resolution of Expert Panel for the Targeted Therapy of Paroxysmal Nocturnal Hemoglobinuria
240-242
01.04.2019
Resolution of the expert committee on the treatment of refractory forms of follicular lymphoma
231-232
01.04.2016
Resolution of the expert council on the treatment of chronic lymphocytic leukemia in patients with concomitant diseases
233-234
01.04.2016
Press-Release of F. Hoffmann-La Roche Ltd.
235-236
01.04.2016
Press-Release of F. Hoffmann-La Roche Ltd., 29 July 2014 , Basel
369-370
01.07.2014
Press-Release of F. Hoffmann-La Roche Ltd.
249-250
01.04.2014
oa-antiplagiat
Make a Submission
Make a Submission
Banner ROHS
Indexing Databases
Editor-in-Chief
Gayane Sepugovna Tumyan
ARCHIVE
2026
Issue 1 (2026)
2025
Issue 1 (2025)
Issue 2 (2025)
Issue 3 (2025)
Issue 4 (2025)
2024
Issue 1 (2024)
Issue 2 (2024)
Issue 3 (2024)
Issue 4 (2024)
2023
Issue 1 (2023)
Issue 2 (2023)
Issue 3 (2023)
Issue 4 (2023)
2022
Issue 1 (2022)
Issue 2 (2022)
Issue 3 (2022)
Issue 4 (2022)
2021
Issue 1 (2021)
Issue 2 (2021)
Issue 3 (2021)
Issue 4 (2021)
2020
Issue 1 (2020)
Issue 2 (2020)
Issue 3 (2020)
Issue 4 (2020)
2019
Issue 1 (2019)
Issue 2 (2019)
Issue 3 (2019)
Issue 4 (2019)
2018
Issue 1 (2018)
Issue 2 (2018)
Issue 3 (2018)
Issue 4 (2018)
2017
Issue 1 (2017)
Issue 2 (2017)
Issue 3 (2017)
Issue 4 (2017)
2016
Issue 1 (2016)
Issue 2 (2016)
Issue 3 (2016)
Issue 4 (2016)
2015
Issue 1 (2015)
Issue 2 (2015)
Issue 3 (2015)
Issue 4 (2015)
2014
Issue 1 (2014)
Issue 2 (2014)
Issue 3 (2014)
Issue 4 (2014)
2013
Issue 1 (2013)
Issue 2 (2013)
Issue 3 (2013)
Issue 4 (2013)
ALL ARCHIVE
Keywords
Most Read Articles
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2024)
3518
National Clinical Guidelines on Diagnosis and Treatment of Ph-Negative Myeloproliferative Neoplasms (Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis) (Edition 2020)
1768
Efficacy and Safety of Glofitamab Therapy in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A United Russian Experience Based on the Compassionate Use Program
1240
Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
1148
Phase 3 Clinical Trial of 300 mg Vamotinib Directly Compared with High-Dose Imatinib in Chronic Myeloid Leukemia Patients in Chronic Phase with Failure of Standard-Dose Imatinib: Interim Analysis
997
Up